A multicenter, open label trial of azithromycin for the treatment of children with acute otitis media

Pediatric Infectious Disease Journal

Volumn 15, Issue 9 SUPPL., 1996, Pages

  McCarty, James ^a,b  

^a California Medical Research Group   (United States)

^b McCarty/Hernon Research Associates   (United States)

Author keywords

azithromycin; otitis media; Pediatric; tympanocentesis

Indexed keywords

AZITHROMYCIN;

ADOLESCENT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CHILD; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HAEMOPHILUS INFLUENZAE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; MULTICENTER STUDY; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PRIORITY JOURNAL; SKIN TOXICITY; STREPTOCOCCUS PNEUMONIAE;

ACUTE DISEASE; ADOLESCENT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HAEMOPHILUS INFECTIONS; HUMANS; MALE; MORAXELLA (BRANHAMELLA) CATARRHALIS; NEISSERIACEAE INFECTIONS; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS;

EID: 0029791114     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199609000-00001     Document Type: Article

References (21)

1. Lisby-Sutch SM, Nemec-Dwyer MA, Deeter RG, Gaur SM. Therapy of otitis media. Clin Pharm 1990;9:15-34.
2. Harrison CJ, Marks MI, Welch DF. Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media. Pediatr Infect Dis J 1985;4:641-6.
3. Kenna MA, Bluestone CD, Fall P, et al. Cefixime vs. cefaclor in the treatment of acute otitis media in infants and children. Pediatr Infect Dis J 1987;6:992-6.
4. Odio CM, Kusmiesz H, Shelton S, Nelson JD. Comparative treatment trial of Augmentin versus cefaclor for acute otitis media with effusion. Pediatrics 1985;75:819-26.
5. Pichichero ME. Therapeutic considerations for management of otitis media, sinusitis, and tonsillopharyngitis. Pediatr Asthma Allergy Immunol 1992;6:167-74.
6. Pichichero M, Aronovitz GH, Gooch WM, et al. Comparison of cefuroxime axetil, cefaclor, and amoxicillin-clavulanate potassium suspensions in acute otitis media in infants and children. South Med J 1990;83:1174-7.
7. Hopkins S. Clinical safety and tolerance of azithromycin in children. J Antimicrob Chemother 1993;31(Suppl E):111-7.
8. Retsema J, Girard A, Schelkly W, et al. Spectrum and mode of action of azithromycin (CP-62 993), a new 15-membered-ring macrolide with improved potency against Gram-negative organisms. Antimicrob Agents Chemother 1987;31:1939-47.
9. Hardy DJ, Hensey DM, Beyer JM, Vojtko C, McDonald EJ, Fernandes PB. Comparative in vitro activity of new 14-, 15-, and 16-membered macrolides. Antimicrob Agents Chemother 1988;32:1710-9.
10. Brown SD, Burton PH, Rich T, Bouchillon SK, Yee YC. Susceptibility surveillance of U.S. respiratory pathogen isolates to newer macrolide and azalide antibiotics [Abstract A32]. In: Program and abstracts of the 94th general meeting of the American Society for Microbiology. Washington, DC: Books International, 1994:7.
11. Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990;25(Suppl A):73-82.
12. Nahata MC, Koranyi KI, Gadgil SD, Hilligoss DM, Fouda HG, Gardner MJ. Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. Antimicrob Agents Chemother 1993;37:314-6.
13. Pukander J. Penetration of azithromycin into middle ear effusion in acute and secretory otitis media in children [Abstract 199], Presented at the Second International Conference on the Macrolides, Azalides and Streptogramins, Venice, Italy, January 19 to 22, 1994.
14. Mohs E, Rodriguez-Solares A, Rivas E, El Hoshy Z. A comparative study of azithromycin and amoxycillin in paediatric patients with acute otitis media. J Antimicrob Chemother 1993;31(Suppl E):73-9.
15. Manfredi R, Jannuzzi C, Mantero E, et al. Clinical comparative study of azithromycin versus erythromycin in the treatment of acute respiratory tract infections in children. J Chemother 1992;4:364-70.
16. Pestalozza G, Cioce C, Facchini M. Azithromycin in upper respiratory tract infections: a clinical trial in children with otitis media. Scand J Infect Dis 1992;83(Suppl):22-5.
17. Schaad UB. Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children. J Antimicrob Chemother 1993;31(Suppl E):81-8.
18. Daniel RR. Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children. J Antimicrob Chemother 1993;31(Suppl E):65-71.
19. Wu DH. Efficacy and tolerability of cefixime in otitis media: a multicentre study in over 25 000 children. Drugs 1991; 42(Suppl 4):30-2.
20. Bluestone CD. Current therapy for otitis media and criteria for evaluation of new antimicrobial agents. Clin Infect Dis 1992;14(Suppl 2):S197-203.
21. Klein JO. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J 1993;12:973-5.